Keratolytics for psoriasis: Are they necessary?

Dermatology Online Journal

Volumn 15, Issue 1, 2009, Pages

  McClain, Richard ^a   Yentzer, Brad A ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CLOBETASOL; KERATOLYTIC AGENT;

CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; NOTE; PSORIASIS; SCORING SYSTEM; SKIN PENETRATION; TREATMENT RESPONSE; ARTICLE;

HUMANS; KERATOLYTIC AGENTS; PSORIASIS;

EID: 59149085589     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Note

References (12)

1. Rook A, Burns T, Breathnach S, Cox N, Griffiths C: Rook's textbook of dermatology. ed 7th, 2004.
2. Habif TP: Psoriasis and other papulosquamous diseases; Clinical dermatology : a color guide to diagnosis and therapy. Philadelphia, Mosby, 2004.
3. Bolognia J, Jorizzo JL, Rapini RP: Dermatology. New York, Mosby, 2003.
4. Katz HI, Lindholm JS, Weiss JS, Shavin JS, Morman M, Bressinck R, Cornell R, Pariser DM, Pariser RJ, Weng W, .: Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis. Clin Ther 1995;17:390-401. [PubMed]
5. Andreassi L, Giannetti A, Milani M: Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients. Br J Dermatol 2003;148:134-138. [PubMed]
6. Griffiths CE, Finlay AY, Fleming CJ, Barker JN, Mizzi F, Arsonnaud S: A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. J Dermatolog Treat 2006;17:90-95. [PubMed]
7. Broby-Johansen U, Karlsmark T, Petersen LJ, Serup J: Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing - skin-thickness, blood-flow and colour measurements compared to clinical assessments. Clin Exp Dermatol 1990;15:343-348. [PubMed]
8. Reygagne P, Mrowietz U, Decroix J, de Waard-van der Spek FB, Acebes LO, Figueiredo A, Caputo R, Poncet M, Arsonnaud S: Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis. J Dermatolog Treat 2005;16:31-36. [PubMed]
9. Beutner K, Chakrabarty A, Lemke S, Yu K: An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis. J Drugs Dermatol 2006;5:357-360. [PubMed]
10. Angelo JS, Kar BR, Thomas J: Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study. Indian J Dermatol Venereol Leprol 2007;73:65. [PubMed]
11. Serup J, Blichmann C: Epidermal hydration of psoriasis plaques and the relation to scaling. Measurement of electrical conductance and transepidermal water loss. Acta Derm Venereol 1987;67:357-359. [PubMed]
12. Schaefer H, Zesch A, Stuttgen G: Penetration, permeation, and absorption of triamcinolone acetonide in normal and psoriatic skin. Arch Dermatol Res 1977;258:241-249. [PubMed]